SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Stacy L. Schmidt, David Bryman, Frank L. Greenway, Ed J. Hendricks, How Physician Obesity Medicine Specialists Treated Obesity before 2012 New Drug Approvals, Obesity Surgery, 2015, 25, 1, 186

    CrossRef

  2. 2
    E J Hendricks, M Srisurapanont, S L Schmidt, M Haggard, S Souter, C L Mitchell, D G De Marco, M J Hendricks, Y Istratiy, F L Greenway, Addiction potential of phentermine prescribed during long-term treatment of obesity, International Journal of Obesity, 2014, 38, 2, 292

    CrossRef

  3. 3
    W. Timothy Garvey, Alan J. Garber, Jeffrey I. Mechanick, George A. Bray, Samuel Dagogo-Jack, Daniel Einhorn, George Grunberger, Yehuda Handelsman, Charles H. Hennekens, Daniel L. Hurley, Janet McGill, Pasquale Palumbo, Guillermo Umpierrez, American Association of Clinical Endocrinologists and American College of Endocrinology Consensus Conference on Obesity: Building an Evidence Base for Comprehensive Action, Endocrine Practice, 2014, 20, 9, 956

    CrossRef

  4. 4
    Martin F. Casey, Jeffrey I. Mechanick, Anti-Obesity Agents and the US Food and Drug Administration, Current Obesity Reports, 2014, 3, 3, 361

    CrossRef

  5. 5
    Jens Jordan, Arne Astrup, Stefan Engeli, Krzysztof Narkiewicz, Wesley W. Day, Nick Finer, Cardiovascular effects of phentermine and topiramate, Journal of Hypertension, 2014, 32, 6, 1178

    CrossRef

  6. 6
    Ryan T. Hurt, Jithinraj Edakkanambeth Varayil, Jon O. Ebbert, New Pharmacological Treatments for the Management of Obesity, Current Gastroenterology Reports, 2014, 16, 6

    CrossRef

  7. 7
    Kathleen E. Corey, Lee M. Kaplan, Obesity and Liver Disease, Clinics in Liver Disease, 2014, 18, 1, 1

    CrossRef

  8. 8
    Vojtech Hainer, Irena Aldhoon-Hainerová, Tolerability and Safety of the New Anti-Obesity Medications, Drug Safety, 2014, 37, 9, 693

    CrossRef

  9. 9
    D J Heal, J Gosden, S L Smith, A review of late-stage CNS drug candidates for the treatment of obesity, International Journal of Obesity, 2013, 37, 1, 107

    CrossRef

  10. 10
    Bruno Halpern, André M Faria, Alfredo Halpern, Fixed-dose combination of phentermine–topiramate for the treatment of obesity, Expert Review of Clinical Pharmacology, 2013, 6, 3, 235

    CrossRef

  11. 11
    Robert R. Henry, Robert Chilton, W. Timothy Garvey, New options for the treatment of obesity and type 2 diabetes mellitus (narrative review), Journal of Diabetes and its Complications, 2013, 27, 5, 508

    CrossRef

  12. You have free access to this content12
    Lewis Landsberg, Louis J. Aronne, Lawrence J. Beilin, Valerie Burke, Leon I. Igel, Donald Lloyd-Jones, James Sowers, Obesity-Related Hypertension: Pathogenesis, Cardiovascular Risk, and Treatment, The Journal of Clinical Hypertension, 2013, 15, 1
  13. 13
    Lewis Landsberg, Louis J. Aronne, Lawrence J. Beilin, Valerie Burke, Leon I. Igel, Donald Lloyd-Jones, James Sowers, Obesity-related hypertension: Pathogenesis, cardiovascular risk, and treatment—A position paper of the The Obesity Society and the American Society of Hypertension, Obesity, 2013, 21, 1
  14. 14
    Harold E. Bays, Peter P. Toth, Penny M. Kris-Etherton, Nicola Abate, Louis J. Aronne, W. Virgil Brown, J. Michael Gonzalez-Campoy, Steven R. Jones, Rekha Kumar, Ralph La Forge, Varman T. Samuel, Obesity, adiposity, and dyslipidemia: A consensus statement from the National Lipid Association, Journal of Clinical Lipidology, 2013, 7, 4, 304

    CrossRef

  15. 15
    Domenica M Rubino, Kishore M Gadde, A review of topiramate and phentermine: a combined therapeutic approach for obesity, Clinical Lipidology, 2012, 7, 1, 13

    CrossRef

  16. 16
    N Gesundheit, Filling the treatment gap in the weight management of overweight and obese patients, International Journal of Obesity Supplements, 2012, 2, S39

    CrossRef

  17. 17
    A.J. Scheen, L.F. Van Gaal, Médicaments de l’obésité et risque cardiovasculaire, Médecine des Maladies Métaboliques, 2012, 6, 1, 31

    CrossRef

  18. 18
    E. J. Hendricks, R. B. Rothman, Phentermine therapy for obesity does not elevate blood pressure, Diabetes, Obesity and Metabolism, 2011, 13, 10